"RANDOX" RIQAS Glycated Haemoglobin (HbA1c) Programme (Non-Sterile) - Taiwan Registration 76ff9e7f02457d42d22e1817216ba8d7
Access comprehensive regulatory information for "RANDOX" RIQAS Glycated Haemoglobin (HbA1c) Programme (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 76ff9e7f02457d42d22e1817216ba8d7 and manufactured by RANDOX LABORATORIES LTD.. The authorized representative in Taiwan is SCN TRADING COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
76ff9e7f02457d42d22e1817216ba8d7
Ministry of Health Medical Device Import No. 017327
DHA09401732707
Product Details
Limited to the first level identification range of quality control materials (analytical and non-analytical) (A.1660) of the Measures for the Administration of Medical Devices.
A Clinical chemistry and clinical toxicology
A1660 Quality Control Materials (Analytical and Non-Analytical)
Imported from abroad
Dates and Status
Dec 22, 2016
Dec 22, 2021